Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Minimal trauma fractures and osteoporosis, deadly but ignored...how do we solve this?, 7/30/2021 8:00:00 AM - 7/30/2024 9:00:00 AM, Participants in Medicine Grand Rounds will be able to identify the most current treatment guidelines, innovations, and standards of practice, and apply them to improve the care of individual patients, promote health and wellness in the population, and achieve clinical quality and safety goals. These educational activities are grounded in principles of health equity, evidence based medicine, inter-professional teamwork, patient-centered care, and respect for human dignity.
Presenter
Ugis Gruntmanis, MD
Professor of Medicine
Geisel School of Medicine at Dartmouth
Section of Endocrinology & Metabolism
Dartmouth-Hitchcock Medical Center
About our presenter:
Dr. Ugis Gruntmanis completed medical school at Riga Stradins University in Latvia, his internship in Internal Medicine at Yale, residency at University of Rochester, and fellowship in endocrinology at the Cedars-Sinai/UCLA program. His clinical and research interests focus on osteoporosis and improvement of care for patients with osteoporosis and osteoporosis-related fractures.
Learning Outcome(s)
At the conclusion of this learning activity, participants will be able to apply updated, evidence-based guidelines to patient care in order to improve the health and wellness of individual patients with minimal trauma fractures and osteoporosis.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Ugis Gruntmanis, MD
Professor of Medicine
Geisel School of Medicine at Dartmouth
Section of Endocrinology & Metabolism
Dartmouth-Hitchcock Medical Center
About our presenter:
Dr. Ugis Gruntmanis completed medical school at Riga Stradins University in Latvia, his internship in Internal Medicine at Yale, residency at University of Rochester, and fellowship in endocrinology at the Cedars-Sinai/UCLA program. His clinical and research interests focus on osteoporosis and improvement of care for patients with osteoporosis and osteoporosis-related fractures.
Learning Outcome(s)
At the conclusion of this learning activity, participants will be able to apply updated, evidence-based guidelines to patient care in order to improve the health and wellness of individual patients with minimal trauma fractures and osteoporosis.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual’s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
